Literature DB >> 11741822

Lung lining liquid modifies PM(2.5) in favor of particle aggregation: a protective mechanism.

Michaela Kendall1, Teresa D Tetley, Edward Wigzell, Bernie Hutton, Mark Nieuwenhuijsen, Paul Luckham.   

Abstract

The health effects of particle inhalation including urban air pollution and tobacco smoke comprise a significant public health concern worldwide, although the mechanisms by which inhaled particles cause premature deaths remain undetermined. In this study, we assessed the physicochemical interactions of fine airborne particles (PM(2.5)) and lung lining liquid using scanning electron microscopy, atomic force microscopy, and X-ray photon spectroscopy. We provide experimental evidence to show that lung lining liquid modifies the chemistry and attractive forces at the surface of PM(2.5), which leads to enhanced particle aggregation. We propose that this is an important protective mechanism that aids particle clearance in the lung.

Entities:  

Mesh:

Year:  2002        PMID: 11741822     DOI: 10.1152/ajplung.2002.282.1.L109

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  11 in total

1.  Nanoparticle growth and surface chemistry changes in cell-conditioned culture medium.

Authors:  Michaela Kendall; Nikolas J Hodges; Harry Whitwell; Jess Tyrrell; Hakan Cangul
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-02-05       Impact factor: 6.237

2.  Nano-technology and nano-toxicology.

Authors:  Robert L Maynard
Journal:  Emerg Health Threats J       Date:  2012-05-29

3.  Comparison of ultrastructural cytotoxic effects of carbon and carbon/iron particulates on human monocyte-derived macrophages.

Authors:  John F Long; W James Waldman; Robert Kristovich; Marshall Williams; Deborah Knight; Prabir K Dutta
Journal:  Environ Health Perspect       Date:  2005-02       Impact factor: 9.031

4.  Surfactant protein A (SP-A) inhibits agglomeration and macrophage uptake of toxic amine modified nanoparticles.

Authors:  Zofi McKenzie; Michaela Kendall; Rose-Marie Mackay; Harry Whitwell; Christine Elgy; Ping Ding; Sumeet Mahajan; Cliff Morgan; Mark Griffiths; Howard Clark; Jens Madsen
Journal:  Nanotoxicology       Date:  2015       Impact factor: 5.913

5.  Modulation of gene expression in Actinobacillus pleuropneumoniae exposed to bronchoalveolar fluid.

Authors:  Abdul G Lone; Vincent Deslandes; John H E Nash; Mario Jacques; Janet I Macinnes
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

Review 6.  Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease.

Authors:  Sean H Ling; Stephan F van Eeden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-06-11

7.  Visualization and quantitative analysis of nanoparticles in the respiratory tract by transmission electron microscopy.

Authors:  Christian Mühlfeld; Barbara Rothen-Rutishauser; Dimitri Vanhecke; Fabian Blank; Peter Gehr; Matthias Ochs
Journal:  Part Fibre Toxicol       Date:  2007-11-12       Impact factor: 9.400

8.  Combustion-derived ultrafine particles transport organic toxicants to target respiratory cells.

Authors:  Arthur Penn; Gleeson Murphy; Steven Barker; William Henk; Lynn Penn
Journal:  Environ Health Perspect       Date:  2005-08       Impact factor: 9.031

9.  Modeling In Vivo Interactions of Engineered Nanoparticles in the Pulmonary Alveolar Lining Fluid.

Authors:  Dwaipayan Mukherjee; Alexandra Porter; Mary Ryan; Stephan Schwander; Kian Fan Chung; Teresa Tetley; Junfeng Zhang; Panos Georgopoulos
Journal:  Nanomaterials (Basel)       Date:  2015-09       Impact factor: 5.076

10.  Translocation of Functionalized Multi-Walled Carbon Nanotubes across Human Pulmonary Alveolar Epithelium: Dominant Role of Epithelial Type 1 Cells.

Authors:  Pakatip Ruenraroengsak; Shu Chen; Sheng Hu; Jodie Melbourne; Sinbad Sweeney; Andrew J Thorley; Jeremy N Skepper; Milo S P Shaffer; Teresa D Tetley; Alexandra E Porter
Journal:  ACS Nano       Date:  2016-04-21       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.